Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Surface Ophthalmics Logo
Surface Ophthalmics Growth Score
64
CB Rank
60706
Heat Score
64
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Pleasanton, California, United States1-10 surfaceophthalmics.com
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Overview

Surface Ophthalmics
Total Funding
obfuscation
Growth Score
64
Heat Score
64

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score64
-1 pts
in past quarter
Heat Score 64
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Surface Ophthalmics

CB Rank
60706
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Pleasanton, California, United States1-10 surfaceophthalmics.com
Biotechnology
Health Care
Pharmaceutical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Surface Ophthalmics, Inc.
Operating Status Active
Company Type For Profit
Founders  Kamran Hosseini, Mark Baum
About the Company
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases. The company's current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle. Surface Ophthalmics was founded in 2017 and is based in Pleasanton, California.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Mycosol (Surf-101)
A prescription eye drop delivering mycophenolate to suppress ocular surface inflammation and promote tear film mucin production in chronic dry eye disease.
Betasol (Surf-201)
A topical steroid eye drop containing betamethasone for reducing postoperative ocular inflammation and pain following surgery.

Research & Development

Surface Ophthalmics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Surface Ophthalmics Logo
Venture Round - Surface Ophthalmics
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•Jul 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

287
37.98%
 in past month

IT Spend

$86KThis year, Surface Ophthalmics is projected to spend $86K on IT, according to Aberdeen.

Active Website Tech Count

3Surface Ophthalmics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, IPhone / Mobile Compatible, and  CommonCrawl Top 50m.

Total IP

11The intellectual property of Surface Ophthalmics includes 7 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Surface Ophthalmics has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Surface Ophthalmics's headquarters? Surface Ophthalmics is located in Pleasanton, California, United States.When was the last funding round for Surface Ophthalmics? Surface Ophthalmics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Surface Ophthalmics's competitors? Alternatives and possible competitors to Surface Ophthalmics may include Bausch & Lomb, Iacta Pharmaceuticals, and  Scope.How much funding has Surface Ophthalmics raised to date? Surface Ophthalmics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|